Pharma Engineering ApS — Credit Rating and Financial Key Figures
CVR number: 42133590
Tokhøjvej 34, Vindinge 4000 Roskilde
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 |
| Net sales | ||||
| Gross profit | ||||
| EBIT | ||||
| Net income from associates (fin.) | 2.18 | 5.68 | -4.39 | 1.47 |
| Pre-tax profit | 2.18 | 5.68 | -4.39 | 1.47 |
| Net earnings | 2.18 | 5.68 | -4.39 | 1.47 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Intangible assets total | ||||
| Tangible assets total | ||||
| Holdings in group member companies | 42.18 | 47.87 | 43.47 | 44.95 |
| Investments total | 42.18 | 47.87 | 43.47 | 44.95 |
| Long term receivables total | ||||
| Inventories total | ||||
| Short term receivables total | ||||
| Balance sheet total (assets) | 42.18 | 47.87 | 43.47 | 44.95 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 |
| Other reserves | 2.18 | 7.87 | 3.47 | 4.95 |
| Retained earnings | -2.18 | -5.68 | 4.39 | -1.47 |
| Profit of the financial year | 2.18 | 5.68 | -4.39 | 1.47 |
| Shareholders equity total | 42.18 | 47.87 | 43.47 | 44.95 |
| Non-current liabilities total | ||||
| Current liabilities total | ||||
| Balance sheet total (liabilities) | 42.18 | 47.87 | 43.47 | 44.95 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.